This trial validates the mode of action of this new class of radioenhancer, which potentially opens a large field of clinical applications in soft-tissue sarcoma and possibly other cancers.

Take an active role in your breast cancer care by asking questions about your cancer and its treatment. Here are a list of key questions.

WOBURN, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...

Sofia’s story is far from unique. In Australia, approximately 32,000 children live with life-limiting conditions. Yet, according to the Australian Institute of Health and Welfare, in 2021 alone, an ...

Only when Alix, her husband and their eldest daughter holidayed with Sofia in Bali later that year did things become impossible to ignore. To Alix, Sofia seemed unusually thin, and her stomach was ...